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What is already known on this topic?
 ► Diabetic ketoacidosis (DKA) is a threatening 
event in the course of diabetes either at onset 
or during follow-up.
 ► DKA incidence does not seem to decrease 
despite the awareness campaign, at least at a 
national level.
 ► Awareness campaigns displayed in a smaller 
context (ie, Emilia Romagna region in the Parma 
campaign, or Newcastle area in Australia) seem 
to be more effective.
What this study adds?
 ► DKA incidence has increased in the calendar 
years 2016–2017 compared with 2013–2014, 
either as overall DKA incidence or as severe 
DKA incidence, in Italy.
 ► Compared with the previous survey, a 
decreased incidence rate in DKA has been 
observed in preschool children (under 6 years 
of age).
 ► After their publication, 95% of the Italian 
centres used the DKA recommendation of the 
Italian Society for Pediatric Endocrinology and 
Diabetology.
AbsTrACT
Objective After a previous survey on the incidence of 
diabetic ketoacidosis (DKA) at onset of type 1 diabetes 
in children in 2013–2014 in Italy, we aimed to verify a 
possible decline in the incidence of DKA at onset during 
a national prevention campaign.
Design Prospective observational study.
setting Multicentre study throughout Italy.
Intervention National awareness campaign started in 
November 2015 and held until December 2017.
Patients During 2016 and 2017 we collected data on 
all patients aged 0–18 years with new-onset diabetes.
Main outcome measures DKA (pH <7.30), severe 
DKA (pH <7.1), DKA in children below 6 years and DKA 
treatment according to the Italian Society for Pediatric 
Endocrinology and Diabetology (ISPED) protocol were 
evaluated.
results Records (n=2361) of children with newly 
diagnosed type 1 diabetes were collected from 58 out 
of 68 (85.3%) centres of the original survey participants 
and 100% of the previously surveyed tertiary centres. 
Overall, DKA was observed in 1124 patients, with an 
increased rate when compared with the previous survey 
(47.6% vs 38.5%, p=0.002), and severe DKA in 15.3%. 
In children below 6 years, DKA was observed in 323 out 
of 617 (52.5%) and severe DKA in 16.7%; in this age 
group, occurrence of DKA reduced by 21.3% (p=0.009). 
DKA treatment according to the ISPED guidelines was 
adopted in 95% of the centres, with a 27% improvement 
(p=0.025).
Conclusions During a 2-year awareness campaign, 
DKA at onset of diabetes in children and adolescents 
0–18 years is still common and increased when 
compared with the 2013–2014 survey.
InTrODuCTIOn
In calendar years 2012 and 2013, paediatric endo-
crinologists belonging to the Italian Society for 
Pediatric Endocrinology and Diabetology (ISPED) 
conducted a multicentre retrospective survey,1 the 
aims of which were (1) to evaluate the incidence 
of diabetic ketoacidosis (DKA) at onset of type 1 
diabetes in children and adolescents in Italy, and (2) 
to determine utilisation of the International Society 
for Pediatric and Adolescent Diabetes (ISPAD) 
guidelines about DKA management in various 
centres. In more than 2400 new cases of type 1 
diabetes, the overall incidence of DKA was 38.5%, 
and 10.3% of patients presented in severe DKA (pH 
<7.1). In preschool-aged children (aged 6 years or 
younger), DKA incidence reached more than 70% 
and was severe in 16.6% of cases.1 Only 68% of 
centres reported adoption of the ISPAD guidelines 
to manage DKA, and there was great variation in the 
approach to management.1 These data were consis-
tent with a comprehensive study of DKA incidence 
during a 10-year follow-up in Italy by Cherubini 
et al,2 and with studies published in the same period 
in other European3–5 and Extra European coun-
tries.6 7
Despite several efforts to reduce the occurrence 
of DKA at onset of type 1 diabetes, there continues 
to be an unacceptably high burden of DKA, with an 
incidence rate often more than 30%.
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Figure 1 Advertising poster of the Italian campaign in English. This 
poster is also available in Italian, Arabic, Romanian and Chinese.
Inspired by the successful Parma campaign, which reduced 
DKA incidence at onset of type 1 diabetes8 (even if the posi-
tive effect tended to disappear after some time9), in 2015 we 
decided to launch a nationwide awareness campaign intended to 
prevent DKA at diabetes onset and to pursue the campaign for 2 
years. In the mean time, the Diabetes Study Group of the ISPED 
published its recommendations for DKA treatment10 partly 
based on the ISPAD guidelines,11 with some differences,12 with 
the aim of standardising the management of DKA in all Italian 
paediatric diabetes centres.
The primary aim of the present survey was to prospectively 
evaluate the number of new cases of type 1 diabetes below the 
age of 19 during the awareness campaign (figure 1) throughout 
the calendar years 2016 and 2017. The secondary aim was to 
determine how many Italian centres reported to adhere to the 
Italian recommendations for DKA treatment.10
MeThODs
A national publicity campaign to increase awareness about 
DKA has been launched in Italy in November 2015 and is still 
ongoing, and therefore continued alongside the period of data 
collection. In Italy, quite all children below the age of 6 years and 
most of the older ones (8–14 years of age) are under the care of 
family paediatricians. For this reason the campaign was aimed to 
family paediatricians, and each of them received an advertising 
poster (figure 1) to exhibit in their ambulatory setting. More-
over, they received a monthly newsletter via email, highlighting 
various topics related to DKA. The same advertising poster was 
sent to many schools, asking the principal to exhibit it, as well as 
to families, who receive bimonthly by mail a magazine (Conos-
cere per Crescere, a magazine about growth issues) that features 
various aspects of paediatrics. In total the advertising poster and 
the newsletters were sent to 10 000 family paediatricians, while 
the advertising poster was sent to 250 elementary, junior high or 
high schools.
The awareness campaign was also launched on ISPED’s social 
media (ie, Facebook and Instagram) and was endorsed by two 
famous Italian comedians (Ale e Franz; official website: http://
www. alefranz. com/), who played a short commercial to advertise 
Italian awareness of DKA campaign and was shown on many 
national and regional television channels.
After 31 December 2017, all 68 centres that participated in 
our first survey1 were invited to complete a survey to collect 
data and investigate DKA epidemiology and management in 
patients who presented with new-onset type 1 diabetes during 
the calendar years 2016 and 2017. The survey questions were 
identical to those included in the previous survey.1 To facilitate 
data collection, the survey was web-based and data collection 
was centralised at the Turin centre. Each centre was asked to 
review all records of patients under 19 years of age who had 
diabetes onset between 1 January 2016 and 31 December 2017.
The following information was requested from each patient: 
date of birth, date of diabetes onset, pH value at diabetes onset 
(to evaluate DKA severity), if a published DKA treatment 
protocol was used (eg, ISPED protocol for DKA10 or other) and 
any treatment complication (eg, cerebral oedema).
In the final analysis the following data were analysed: number 
of patients 0–18 years of age with diabetes onset during the 
observation period, number of patients <6 years of age, number 
of patients with DKA (either as a total number or only patients 
<6 years of age), number of patients with severe DKA (either 
as a total number or only patients <6 years of age), number of 
patients who developed cerebral oedema, and number of centres 
following any DKA protocol and which one.
DKA was defined according to the ISPAD criteria11 (eg, blood 
glucose >11 mmol/L (≈200 mg/dL); venous pH <7.3 or bicar-
bonate <15 mmol/L; ketonaemia and ketonuria). The severity 
of DKA was categorised according to the degree of acidosis: 
(1) mild: venous pH <7.3 or bicarbonate <15 mmol/L; (2) 
moderate: pH <7.2 or bicarbonate <10 mmol/L; and (3) severe: 
pH <7.1 or bicarbonate <5 mmol/L.11
Data for the calendar years 2016 and 2017 were pooled for 
analysis, and we used the χ2 test to evaluate possible statistical 
differences between groups; statistical significance was deter-
mined to be p<0.05.
resulTs
Among the 68 centres belonging to the ISPED that participated 
in the first survey,1 58 (85.3%) completed the web-based survey 
and returned complete data records of patients with newly diag-
nosed diabetes. One hundred per cent of the tertiary referral 
centres (n=39) of the ISPED were included among the 58 
centres that responded.
The results of the current survey compared with those of the 
previous one1 are shown in table 1.
In 2016–2017, a total of 2361 children 0–18 years of age were 
diagnosed with type 1 diabetes in the 58 respondent centres, 
and their records were evaluated and reviewed for the present 
report.
DKA was observed in 1123 out of 2361 (47.6%) patients, 
which is a significant increase in DKA incidence compared with 
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Table 1 Diabetic ketoacidosis incidence in the paediatric population 
(0–18 years) in the calendar years 2016 and 2017 in Italy, compared 
with the previous survey in calendar years 2012 and 20131
2012–2013 
survey
2016–2017 
survey P value
Patients with type 1 diabetes onset (n) 2453 2361 –
Preschool patients with type 1 diabetes 
onset, n (%)
618 (26.6) 617 (26.1) –
Patients with DKA at onset, n (%) 945 (38.5) 1124 (47.6) 0.002
Preschool-aged patients with DKA at 
onset, n (%)
445 (73.8) 323 (52.5) 0.009
Patients with severe DKA at onset, n (%) 97 (10.3) 172 (15.3) 0.008
Preschool-aged patients with severe DKA 
at onset, n (%)
103 (16.6) 70 (21.7) 0.008
DKA, diabetic ketoacidosis.
the 2012–2013 survey1 (47.6% vs 38.5%, p=0.002). Similarly, 
the rate of severe DKA was significantly increased (table 1).
With an equal number of preschool-aged children in the two 
surveys (n=617, 26.1% in 2016–2017 vs n=650, 26.7% in 
2012–2013), the incidence of DKA significantly decreased in 
preschool-aged children in 2016–2017 compared with 2012–
2013 (52.5% vs 73.8%, p=0.009) (table 1); however, the rate 
of severe DKA both in preschool-aged children and in the entire 
cohort increased significantly (table 1).
Cerebral oedema was observed in 4 out of 1123 patients with 
DKA in the current cohort (0.35% vs 0.53% in 2012–2013, 
p=0.548). Seven cases of mild DKA occurred in adolescents 
who subsequently were diagnosed with type 2 diabetes at disease 
onset.
Among the 58 respondent centres, 95% reported following 
the ISPED DKA treatment recommendations.10
DIsCussIOn
The present survey provides a comprehensive depiction of DKA 
epidemiology and management in 58 out of 68 centres that 
provided data about newly diagnosed children 0–18 years old 
with type 1 diabetes in Italy during the calendar years 2016 and 
2017, during an awareness campaign, from November 2015 
until the end of 2017. The data collected are considered to repre-
sent DKA at the national level because information was obtained 
from 100% of the tertiary-level centres that participated in the 
previous survey (n=39),1 which provided coverage of approxi-
mately 90% of paediatric diabetes in Italy.
The DKA awareness campaign was directed to family paedi-
atricians throughout Italy. In Italy, since 1978, each child 0–14 
years of age has been assigned to a family paediatrician who is 
responsible for his/her health and disease management. Family 
paediatricians received by mail one or more advertising posters 
(figure 1) to exhibit in their ambulatory setting.
Unfortunately, the reach of the campaign has not been 
measured and only partial figures are available. We sent 10 000 
posters but we have no way to verify if all of them have been 
displayed in the ambulatory setting, as well as how many schools 
displayed the poster.
An earlier prevention campaign8 succeeded in decreasing 
the occurrence of DKA in the Emilia Romagna region but not 
throughout Italy. We thought that an extra effort to reduce the 
occurrence of DKA in new-onset diabetes throughout Italy was 
needed. It is disappointing that the present survey shows the 
campaign coincided with an increase in the incidence of DKA 
in patients with new-onset diabetes. It is difficult to explain the 
reason for the higher incidence in 2016–2017 compared with 
2012–2013. However, the SWEET consortium has presented 
similar data at the last annual conference of the ISPAD.13
Even if the observational study design does not allow for a 
definitive conclusion, it is interesting to note that the aware-
ness of DKA campaign was associated with a significant 30% 
decrease in the incidence of DKA in preschool-aged children. In 
this respect, family paediatricians, the main target of the aware-
ness campaign, might have played an important role in the early 
identification of new-onset diabetes in young children.
A previous national awareness campaign in Austria was 
not able to show a decrease in DKA incidence.14 The authors 
described a DKA incidence of 37.2% for all new-onset diabetes 
in the period 1989–2011, and no difference before and after a 
prevention campaign that was similar to the Parma campaign.14 
By contrast, Vanelli et al8 showed a decrease in DKA incidence 
from 78% to 12%, highlighting the fact that a similar preven-
tion campaign might work better when applied to a small area 
(the Emilia Romagna region) instead of a national area (eg, Italy 
and Austria). Similarly, in a small area (Newcastle area of New 
South Wales, Australia), Bruce King and colleagues15 reported a 
decrease in DKA by 64%.
It is also disappointing that the awareness of DKA campaign 
coincided with a higher incidence of severe DKA when compared 
with 2012–2013 both in the entire cohort and in preschool-
aged children. The reason for this increase is unknown. DKA 
continues to be a threat to all children and adolescents with type 
1 diabetes onset despite the campaign to prevent it. The length 
of the campaign (2 years) may be too short to obtain consistent 
results. The Austrian campaign took 20 years to attain a 13% 
decrease in the DKA incidence at diabetes onset in paediatric 
age.14 Recent data from the USA showed a steadily increasing 
incidence of DKA in both children and adults, but associated 
with a decrease in DKA-associated mortality.16 Moreover, it is 
interesting to note that a recent systematic review of publicity 
interventions to increase awareness among healthcare profes-
sionals and the public to promote earlier diagnosis of type 1 
diabetes in children and young people does not reach a definitive 
conclusion on the effectiveness of the interventions reported.17
The decrease in DKA incidence only in preschool-aged chil-
dren and not in the entire cohort could also be explained by the 
ongoing shortage of family paediatricians observed in Italy in the 
past years, due to a large number of paediatricians retiring in the 
last 5 years and not being replaced by younger paediatricians. 
The lower number of family paediatricians is the reason why 
many families when their children are older than 6 years of age 
move to family physicians (ie, general practitioners), who were 
not the target of the awareness campaign. It is likely that general 
practitioners who care for some older children and adolescents 
may not have been reached by the campaign.
However, despite the increased number of patients with severe 
DKA, a slight, non-significant, decrease in the rate of cerebral 
oedema was observed during 2016–2017. We cannot conclude 
that this improvement could be due to a higher percentage of 
recommendation implementation.10 11 Certainly, the release of the 
ISPED recommendations for the management of DKA in 201510 
enabled a standardisation of the procedures for the management 
and treatment of DKA in the different Italian centres. While in 
the previous report only 68% of the centres claimed to follow 
a treatment protocol based on the ISPAD guidelines, nearly all 
the centres responding to the present survey reported using the 
ISPED/ISPAD recommendations.
As a limitation of this study, we would like to note that despite 
our aim of evaluating whether the campaign was effective in 
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decreasing DKA incidence, it was not possible to determine the 
effectiveness using our study design, as there was no control 
group or experimental design, and changes over time since the 
last study may have been caused by other changes unrelated to 
the campaign. Also, the data were collected while the campaign 
was ongoing, so there was no way of knowing whether the 
decrease would be sustained following the end of the campaign. 
We aim to collect data for the next calendar year to sort this out.
In conclusion the findings of this second nationwide survey 
in the calendar years 2016 and 2017 about the incidence of 
DKA in children and adolescents at the onset of type 1 diabetes 
show that DKA is still common at diabetes onset in children 
and adolescents. A continuous reinforcement of the awareness 
of DKA prevention campaign is needed and should probably be 
implemented. New strategies of communication should probably 
be promoted and supported by scientific societies and national 
health systems, targeting family paediatricians and general prac-
titioners, as well as the whole population, via radio/television/
social media advertising. The Diabetes Study Group of the 
ISPED is currently working to implement a nationwide aware-
ness DKA prevention campaign.
Twitter Andrea Scaramuzza @andreathedoc
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